Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of metformin, pioglitazone and vitamin E on nonalcoholic fatty liver disease
IRCT2013071313069N2Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jun 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin, pioglitazone and vitamin e in metabolic dysfunction-associated steatotic liver disease (MASLD) (3 arms), sponsored by Kermanshah University of Medical Sciences. Started Jun 2007; status: completed.
02
Drugs
metforminpioglitazonevitamin e
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT2013071313069N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013071313069N2.